SA PRO
Free Account
Athira Pharma, Inc.ATHANASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating
Hold
5 analysts·Limited coverage
0%
Rating Distribution
Strong Buy
00%
Buy
00%
Hold
5100%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Current price is 41% above analyst consensus — significant downside expected.

Bear Case
$4.00
-41%
Consensus
$4.00
-41%
Bull Case
$4.00
+-41%
Price Range5 analysts
Low
Consensus
High
$4.00
$4.00
Current Target
Current Price
$6.75
Above Target
$2.75

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Sep 19, 2025Mizuho Securities
Athira Pharma price target lowered to $4 from $5 at Mizuho
Target:$4.00
+4.4%from $3.83
Jun 22, 2022Jefferies
Athira Pharma downgraded to Hold from Buy at Jefferies
Target:$3.00
+5.3%from $2.85
Apr 21, 2022Berenberg Bank
Berenberg Initiates Coverage On Athira Pharma with Buy Rating, Announces Price Target of $33
Target:$33.00
+183.7%from $11.63

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance